Effect of gender on the effective dose of alfentanil in inhibiting the cardiovascular response to double-lumen bronchial intubation

To investigate the effective doses of alfentanil in inhibiting cardiovascular response of double-lumen bronchial intubationIn different genders

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000035870

Enrollment

Unknown

Registered

2020-08-19

Start date

2020-08-31

Completion date

Unknown

Last updated

2020-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular response to double lumen endotracheal intubation

Interventions

Case series:alfentanil will used to inhibit the response of the double-lumen endotracheal intubation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with lung tumor resection under general anesthesia with double lumen bronchial intubation; 2. ASA I - II patients; 3. Patients aged 18-65 years.

Exclusion criteria

Exclusion criteria: 1. Patients with a history of difficult intubation or failure of intubation in this study; 2. Patients with a history of opioid or other sedative drug abuse before operation; 3. Patients with liver, kidney or blood system diseases; 4. Patients with high risk of reflux aspiration; 5. Patients with BMI > 25kg / m2 or < 18kg / m2; 6. Patients with severe cardiopulmonary disease before operation.

Design outcomes

Primary

Measure	Time frame
Mean arterial pressure;Heart rate;	—

Countries

China

Contacts

Public ContactLingyang Chen

Department of Anesthesiology, Taizhou hospital, Zhejiang Province

chenly@enzemed.com+86 13757600208

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026